Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma

Genes Chromosomes and Cancer

Volumn 37, Issue 2, 2003, Pages 201-206

  Moskovitz, Alexander H ^a   Linford, Nancy J ^b   Brentnall, Teresa A ^b   Bronner, Mary P ^b   Storer, Barry E ^c   Potter, John D ^c   Bell Jr , Richard H ^d   Rabinovitch, Peter S ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL CULTURE; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHRONIC PANCREATITIS; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MALE; MICROSATELLITE INSTABILITY; OXIDATIVE STRESS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PRECANCER; PRIORITY JOURNAL; RISK FACTOR;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 18; CHRONIC DISEASE; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATITIS; PRECANCEROUS CONDITIONS; TUMOR CELLS, CULTURED;

EID: 0038408793     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10189     Document Type: Article

References (30)

1. Adsay NV, Dergham ST, Koppitch FC, Dugan MC, Mohamed AN, Vaitkevicius VK, Sarkar FH. 1999. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma. Pancreas 18: 111-116.
2. Balagué C, Audié JP, Porchet N, Real FX. 1995. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissue. Gastroenterology 109:953-964.
3. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andren-Sandberg A, Mitelman F, Heim S. 1993. Karyotypic abnormalities in tumours of the pancreas. Br J Cancer 67:1106-1112.
4. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, Rabinovitch PS, Reid BJ. 1999. Evolution of neoplastic cell lineages in Barretc oesophagus. Nat Genet 22:106-109.
5. Broberg K, Toksvig-Larsen S, Lindstrand A, Mertens F. 2001. Trisomy 7 accumulates with age in solid tumors and non-neoplastic synovia. Genes Chromosomes Cancer 30:310-315.
6. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC, Rubin CE. 1992. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of p53 allele. Gastroenterology 103:1602-1610.
7. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo C, Kern SE. 1994. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54:3568-3573.
8. Greenlee RT, Murray T, Bolden S, Wingo P. 2000. Cancer statistics, 2000. CA Cancer J Clin 50:7-33.
9. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F, Yeo CJ. 1994. Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 9:93-100.
10. Heinmöller E, Dietmaier W, Zirngibl H, Heinmoller P, Searinge W, Jauch K-W, Hofstadter F, Ruschoff J. 2000. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 157:83-92.
11. Kuehn R, Lelkes PI, Bloechle C, Niendorf A, Izbicki JR. 1999. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and pancreatic cancer. Pancreas 18:96-103.
12. Lee CS, Rush M, Charalambous D, Rode J. 1993. Immunohistochemical demonstration of the p53 tumor suppressor gene product in cancer of the pancreas and chronic pancreatitis. J Gastroenterol Hepatol 8:465-469.
13. Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Kloppel G. 1992. The erbB-3 gene in human pancreatic cancer. J Pathol 168:269-273.
14. Lengauer C, Kinzler KW, Vogelstein B. 1997. Genetic instability in colorectal cancers. Nature 386:623-627.
15. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
16. Lewis JG, Adams DO. 1987. Inflammation, oxidative DNA damage, and carcinogenesis. Environ Health Perspect 76:19-27.
17. Lowenfels AB, Maisonneuve P, Lankisch PG. 1999. Chronic pancreatitis and other risk factors for pancreatic cancer. Gastroenterol Clin North Am 28:673-685.
18. Oda D, Savard CE, Nguyen Td, Swenson ER, Lee SP. 1998. Culture of human main pancretic duct epithelial cells. In Vitro Cell Dev Biol Anim 34:211-216.
19. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, Emond MJ, Gollahon KA, Moskovitz AH, Crispin DA, Potter JD, Rabinovitch PS. 2002. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 32:280-284.
20. Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. 1994a. CA50 compared with CA19-9 as a serum tumor marker for pancreatic carcinoma. Ital J Gastroenterol 26: 169-173.
21. Pasquali C, Sperti C, D'Andrea AA, Costantino V, Filipponi C, Pedrazzoli S. 1994b. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9. Int J Pancreatol 15:171-177.
22. Poch B, Gansauge F, Schwarz A, Seufferlein T, Schnelldorfer T, Ramadani M, Beger HG, Gansauge S. 2001. Epidermal growth factor induces cyclin Dl in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression. Pancreas 23: 280-287.
23. Rabinovitch PS, Dzaidon S, Brentnall T, Emond MJ, Crispin DA, Haggit RC, Bronner MP. 1999. Pancolonic chomosomal instability preceedes dysplasia and cancer in ulcerative colitis. Cancer Res 59:5148-5153.
24. Safi F, Roscher R, Beger HG. 1989. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9. Hepatogastroenterology 36:419-423.
25. Sakorafas GH, Tsiotou AG. 1999. Multi-step pancreatic carcinogenesis and its clinical implications. Eur J Surg Oncol 25:562-565.
26. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE. 1994. Allelotype of pancreatic adenocarcinoma. Cancer Res 54:2761-2764.
27. Shih I-M, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. 2001. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61:818-822.
28. van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, Offerhaus GJ, Hicks JL, Wilentz RE, Goggins MG, De Marzo AM, Hruban RH, Maitra A. 2002. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 161:1541-1547.
29. Willenbucher RF, Aust DE, Chang CG, Zelman SJ, Ferrell LD, Moore DH, Waldman FM. 1999. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 154:1825-1830.
30. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T. 2000. Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 156:2123-2133.